MarketScreener Editorial Features Savara Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 05/06/2026 BST			5-day change	1st Jan Change
5.090 ^USD	-3.96%		-2.12%	-15.59%

05-18	Savara Inc Announces New Exercise Capacity Data From The IMPALA-2 Phase 3 Clinical Trial Of Molgramostim Inhalation Solution In Autoimmune Pulmonary Alveolar Proteinosis	CI
05-12	Savara Q1 Loss Widens	MT

No results for this search